Skip to content
Sagimet Biosciences logo

Sagimet Biosciences (SGMT) Q1 2024 Earnings

SGMT·Reported May 15, 2024·Before market open

Diluted EPS came in at $-0.23, beat the $-0.41 consensus by $0.18.

Diluted EPS
$-0.23beat by $0.18
Consensus: $-0.41
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about Sagimet Biosciences's Q1 2024 earnings report.

Sagimet Biosciences (SGMT) reported Q1 2024 earnings on May 15, 2024 before market open.

Sagimet Biosciences reported diluted EPS of $-0.23 for Q1 2024.

EPS beat the consensus estimate of $-0.41 by $0.18.

You can read the 10-Q periodic report (0001558370-24-008205) directly on SEC EDGAR. The filing index links above go to sec.gov.